{"entity":{"id":"ruben-mesa","kind":"person","name":"Ruben Mesa","aka":[],"tldr":"Physician who is Executive Director of the NCI-designated Atrium Health Wake Forest Baptist Comprehensive Cancer Center in Winston-Salem and President of its cancer service line.","summary":"Ruben Mesa is Executive Director of the Atrium Health Wake Forest Baptist Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centre in Winston-Salem, North Carolina, and President of the Cancer Service Line. The cancer centre's own website introduces him under the heading 'Meet Dr. Ruben Mesa, Our New Cancer Center Director', asking readers to welcome him as the new Executive Director of the NCI-designated centre. The page did not give an appointment date or further biographical detail.","asOf":"2026-09-10","links":[{"label":"Source: Wake Forest Baptist cancer centre page introducing the director","url":"https://www.wakehealth.edu/cancer"}],"tags":["leadership","clinician-scientist","comprehensive-cancer-centre"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["wake-forest-cancer"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["cancer-medicine","lancet-haematology","cancers-mdpi"],"dependsOn":[],"notes":[],"role":"Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, and President of the Cancer Service Line","institutionId":"wake-forest-cancer","specialisms":["Haematology and oncology","Cancer centre leadership","Academic medicine"],"profiles":[{"label":"Atrium Health Wake Forest Baptist cancer pages","url":"https://www.wakehealth.edu/cancer"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Mesa+RA%5BAuthor%5D"}],"papers":[{"title":"Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies","journal":"Cancer Medicine","year":2023,"doi":"10.1002/cam4.5799"},{"title":"Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group","journal":"The Lancet Haematology","year":2024,"doi":"10.1016/s2352-3026(23)00305-8"},{"title":"Anemia in Myelofibrosis: A Focus on Proactive Management and the Role of Momelotinib","journal":"Cancers","year":2024,"doi":"10.3390/cancers16234064"}],"orcid":"0000-0001-5880-7972"},"route":"/people/ruben-mesa/","neighbours":{"institution":[{"id":"wake-forest-cancer","kind":"institution","name":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","route":"/institutions/wake-forest-cancer/"}],"journal":[{"id":"cancer-medicine","kind":"journal","name":"Cancer medicine","route":"/journals/cancer-medicine/"},{"id":"cancers-mdpi","kind":"journal","name":"Cancers","route":"/journals/cancers-mdpi/"},{"id":"lancet-haematology","kind":"journal","name":"The Lancet Haematology","route":"/journals/lancet-haematology/"}]}}